日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Altered bile acid and coproporphyrin-I disposition in patients with autosomal dominant polycystic kidney disease

常染色体显性多囊肾病患者胆汁酸和粪卟啉-I代谢改变

Tiley, Jacqueline B; Beaudoin, James J; Derebail, Vimal K; Murphy, William A; Park, Christine C; Veeder, Justin A; Tran, Lana; Beers, Jessica L; Jia, Wei; Stewart, Paul W; Brouwer, Kim L R

Evaluating cannabidiol-induced liver injury with and without valproate using a three-dimensional human hepatocyte spheroid model.

使用三维人肝细胞球体模型评估有无丙戊酸盐治疗下大麻二酚引起的肝损伤

Beers Jessica L, Harvey Shalon L, Lanphier Raeanne M, Rushing Blake R, McRitchie Susan L, Sumner Susan J, Jackson Klarissa D

Transporters and drug secretion into human breast milk

转运蛋白和药物分泌到人乳中

Beers, Jessica L; Hebert, Mary F; Wang, Joanne

CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions

特殊人群中CBD和THC:药代动力学和药物相互作用

Qian, Lixuan; Beers, Jessica L; Jackson, Klarissa D; Zhou, Zhu

Interindividual variability in CYP3A-mediated venetoclax metabolism in vitro and in vivo in patients with chronic lymphocytic leukemia

慢性淋巴细胞白血病患者体外和体内CYP3A介导的维奈托克代谢的个体间差异

Lee, Jonghwa; Beers, Jessica L; Cheng, Isabel; Truong, Vivian; Brown, Zachary; Muluneh, Benyam; Coombs, Catherine C; Jackson, Klarissa D

WHO CAN USE YOUR CELLS OR TISSUES FOR SCIENTIFIC RESEARCH?

谁可以使用您的细胞或组织进行科学研究?

Beers, Jessica L; Geffert, Raeanne M; Latham, Bethany D; Jackson, Klarissa D

Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine

表征个体药物代谢和推进精准医疗的新方法

Jackson, Klarissa D; Achour, Brahim; Lee, Jonghwa; Geffert, Raeanne M; Beers, Jessica L; Latham, Bethany D

Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol

胞质酶生成大麻素代谢物7-羧基大麻二酚和11-去甲-9-羧基四氢大麻酚

Beers, Jessica L; Authement, Aurora K; Isoherranen, Nina; Jackson, Klarissa D

Verifying in vitro-determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically-based pharmacokinetic modeling

通过基于生理的药代动力学模型,验证体外测定的酶对大麻二酚清除率的贡献,以预测人体内的暴露量。

Yeung, Cindy H T; Beers, Jessica L; Jackson, Klarissa D; Edginton, Andrea N

Case Study 11: Considerations for Enzyme Mapping Experiments-Interaction Between the Aldehyde Oxidase Inhibitor Hydralazine and Glutathione

案例研究 11:酶图谱实验的注意事项——醛氧化酶抑制剂肼屈嗪与谷胱甘肽的相互作用

Crouch, Rachel D; Beers, Jessica L; Jackson, Klarissa D